FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 114,331,829
Number of holders: 22
Total 13F shares, excl. options: 10,270,522
Shares change: +416,558
Total reported value, excl. options: $52,580,000
Value change: +$2,082,379
Number of buys: 13
Number of sells: -7
Price: $5.1

Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2014

25 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q3 2014.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10,270,522 shares of 114,331,829 outstanding shares and own 8.98% of the company stock.
Largest 10 shareholders include FMR LLC (3,076,573 shares), Polaris Venture Management Co. V, L.L.C. (2,473,186 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1,427,675 shares), WELLINGTON MANAGEMENT CO LLP (1,418,975 shares), ORBIMED ADVISORS LLC (692,900 shares), Board of Trustees of The Leland Stanford Junior University (291,000 shares), PRINCIPAL FINANCIAL GROUP INC (203,100 shares), VANGUARD GROUP INC (171,938 shares), FARALLON CAPITAL MANAGEMENT LLC (171,196 shares), and GOLDMAN SACHS GROUP INC (83,692 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.